Weekly Newsletter Signup | Vendors, CIO Viewpoint, CXO Insights
Pharma Tech Outlook

Pharma Tech Outlook: Weekly Brief

News Letter Subscription

Weekly Brief

Subscribe

Weekly Brief

Sep 3, 2026

Featured Vendors

Mikio Toda, President and Representative DirectorMikihiro Toda, Representative Director, Executive Managing Officer, Corporate Planning Div  
Fuso Pharmaceutical Industries is a pioneer in dialysis drug development, delivering clinically precise, patient-specific hemodialysis solutions backed by unrivaled supply stability. With six decades of market leadership, deep collaboration with... Read more
Mukhtar Ahmed, CEO  
BC Platforms helps life sciences organisations turn distributed clinical, genomic, imaging and real-world data into research-ready evidence through federated access, harmonisation, secure analytics and AI-enabled workflows, supporting faster... Read more

CXO Insights

By Gary Fling, CIO, Phibro Animal Health Corporation  
Gary Fling is a trailblazer in information management and technology, with over 40 years of experience...  Read more
By Cori L. Rizman, Vice President of DEA Compliance, Ascent Pharmaceuticals, Inc  
I’ve been fortunate to have leaders who modeled consistency, fairness, candor, and most importantly,...  Read more
By Leandro Domingues, Senior Engagement Manager, and Audrey Lee, Consultant, Syneos Health Commercial Solutions  
Growing momentum behind the United States Most Favored Nation (MFN) drug pricing policy is forcing...  Read more

Feature of the Week

Achieving sustainable compliance in the pharmaceutical industry demands a strong organizational culture, proactive risk management, seamless technology integration, and continuous awareness of evolving regulatory requirements.  Read more
ESG principles to reduce environmental impact, improve social equity, and enhance governance transparency. This shift drives innovation, builds stakeholder trust, and ensures long-term value for society and business.  Read more